Checklist to Assess Risk Factors & Drivers Impacting Valuation in Pharma/Biotech

Valuations in pharma and biotech are driven by assumptions that vary widely based on the unique risk profile of the company or product. CELforPharma faculty member Dr. Patrik Frei, from Pharma-Biotech Product & Company Valuation, has made a handy checklist. It helps you identify critical factors and provides a framework for assessing aspects that could influence the valuation. 

Download now

I accept that relevant personal details are stored in a database for that purpose, as per our Privacy Policy, of which I accept the terms. *
Checklist to Assess Risk Factors & Drivers Impacting Valuation in Pharma/Biotech

 

 

Learn more about this topic at the following short duration course(s):

Pharma-Biotech Product & Company Valuation
With Dr. Patrik Frei
Dr. Patrik Frei

 

 

Subscribe to CELforPharma's newsletter to receive tips & insights from our expert faculty:

 

Please indicate your domains of interest:

By subscribing to this newsletter, I accept the Privacy Policy.